The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study

被引:19
作者
Dunn, NR [1 ]
Arscott, A
Thorogood, M
机构
[1] Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England
[2] London Sch Hyg & Trop Med, London WC1 6FH, England
关键词
oral contraceptives; myocardial infarction; risk of fatality;
D O I
10.1016/S0010-7824(01)00172-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
To examine the relationship between use of oral contraceptives and the risk of dying from myocardial infarction, we made a comparison of deceased patients and live patients (women aged less than 45) identified for the Myocardial Infarction Causality case-control study, using data obtained from general practice medical notes. There were 422 live patients and 110 deceased patients of women with a myocardial infarction with data available. The adjusted odds ratio for exposure to second generation oral contraceptives and risk of death within 28 days of a myocardial infarction compared with no oral contraceptive use was raised (2.88, 95% confidence interval 1.21-6.77), and this effect was not seen for other types of oral contraceptives including third generation oral contraceptive formulations. In absolute terms, between 47,000 and 71,000 women would have to be exposed to a second generation pill for one year to result in one extra death from myocardial infarction, and this risk applies mainly to smokers. The results suggest a slightly increased relative risk of death among those having a myocardial infarction associated with exposure to second generation oral contraceptives, but this represents a small absolute risk. Further work is required before any change in contraceptive practice should be advocated. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 20 条
  • [1] Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46,000 women from Royal College of General Practitioners' oral contraception study
    Beral, V
    Hermon, C
    Kay, C
    Hannaford, P
    Darby, SA
    Reeves, G
    [J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7176) : 96 - 100
  • [2] Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed"
    Bjerre, LM
    LeLorier, J
    [J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7233) : 503 - 506
  • [3] ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN
    BLOEMENKAMP, KWM
    ROSENDAAL, FR
    HELMERHORST, FM
    BULLER, HR
    VANDENBROUCKE, JP
    [J]. LANCET, 1995, 346 (8990): : 1593 - 1596
  • [4] Oral contraceptives and myocardial infarction: results of the MICA case-control study
    Dunn, N
    Thorogood, M
    Faragher, B
    de Caestecker, L
    MacDonald, TM
    McCollum, C
    Thomas, S
    Mann, R
    [J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7198) : 1579 - 1583
  • [5] Dunn NR, 1997, PHARMACOEPIDEM DR S, V6, P283, DOI 10.1002/(SICI)1099-1557(199707)6:4<283::AID-PDS270>3.0.CO
  • [6] 2-F
  • [7] Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales
    Dunn, NR
    Arscott, A
    Thorogood, M
    Faragher, B
    de Caestecker, L
    MacDonald, TM
    McCollum, C
    Thomas, S
    Mann, RD
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (04) : 293 - 298
  • [8] Risk of myocardial infarction in young female smokers
    Dunn, NR
    Faragher, B
    Thorogood, M
    de Caestecker, L
    MacDonald, TM
    McCollum, C
    Thomas, S
    Mann, R
    [J]. HEART, 1999, 82 (05) : 581 - 583
  • [9] GREAVES M, 1996, OXFORD TXB MED
  • [10] EFFECTS OF NEVER ORAL-CONTRACEPTIVES ON THE INHIBITION OF COAGULATION AND FIBRINOLYSIS IN RELATION TO DOSAGE AND TYPE OF STEROID
    JESPERSEN, J
    PETERSEN, KR
    SKOUBY, SO
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 396 - 403